Bayesian Capital Management’s Emcor EME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-613
Closed -$398K 256
2025
Q3
$398K Buy
+613
New +$372K 0.08% 328
2025
Q2
Sell
-2,763
Closed -$1.02M 637
2025
Q1
$1.02M Buy
2,763
+1,276
+86% +$552K 0.17% 163
2024
Q4
$675K Buy
+1,487
New +$704K 0.08% 311
2024
Q3
Sell
-3,330
Closed -$1.22M 779
2024
Q2
$1.22M Buy
3,330
+662
+25% +$244K 0.14% 194
2024
Q1
$934K Buy
2,668
+415
+18% +$111K 0.09% 301
2023
Q4
$485K Buy
2,253
+593
+36% +$124K 0.05% 395
2023
Q3
$349K Sell
1,660
-2,694
-62% -$564K 0.04% 434
2023
Q2
$805K Buy
4,354
+300
+7% +$50.2K 0.09% 313
2023
Q1
$659K Buy
4,054
+1,755
+76% +$270K 0.08% 322
2022
Q4
$341K Sell
2,299
-7,900
-77% -$1.12M 0.05% 446
2022
Q3
$1.18M Buy
10,199
+7,800
+325% +$891K 0.24% 112
2022
Q2
$247K Buy
+2,399
New +$256K 0.05% 542
2018
Q1
Sell
-8,079
Closed -$660K 641
2017
Q4
$660K Sell
8,079
-1,300
-14% -$101K 0.13% 258
2017
Q3
$651K Buy
+9,379
New +$621K 0.16% 215
2017
Q1
Sell
-12,200
Closed -$863K 483
2016
Q4
$863K Buy
+12,200
New +$799K 0.21% 170

Other funds holding EME

Bayesian Capital Management's EME Position: Q4 2025 in Review

Bayesian Capital Management sold out of Emcor (EME) in Q4 2025, closing a stake of 613 shares — an estimated $398K sold.

Bayesian Capital Management first reported a position in EME in Q4 2016 and held it in 15 quarters. The position peaked at $1.22M in Q2 2024. 1,093 funds tracked by Wall St. Rank hold EME as of Q4 2025.

  • Bayesian Capital Management reported no remaining Emcor position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 613 Emcor shares in Q4 2025, an estimated $398K.
  • Bayesian Capital Management first reported a position in Emcor in Q4 2016 and held it in 15 quarters.
  • Bayesian Capital Management's Emcor position peaked at $1.22M in Q2 2024.
  • 1,093 funds tracked by Wall St. Rank held Emcor as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.